consultancy

In Asia, the incidence of kidney disease of all types is growing more rapidly than developed western countries in part due to increasing rates of diabetes and hypertension. Across the continent, the population of end-stage renal disease patients requiring dialysis is growing at an annual rate of more than 12%. This rapid growth is proving costly.

Most kidney diseases are untreated or undetected in its earliest stages and is expensive to manage as it progresses to end stage renal failure. There are a host of technological advances and discovery of novel serum biomarkers in renal disease treatment and management but what many clinicians and health governments hope for now is early detection. Recognition of a kidney dysfunction in the earliest stages will have the largest impact to reducing social and economic burdens.

Perspectives of Urinalysis in Nephrology Practice
Click here to learn more

Solutions

products_default

Chronic Kidney Disease – The silent killer

Read more

Chronic Kidney Disease – The silent killer

Read more
products_default

Kidney Biomarkers – Early detection, enhanced monitoring

Read more

Kidney Biomarkers – Early detection, enhanced monitoring

Read more
products_default

RBC Morphology – A useful parameter in Renal Disease

Read more

RBC Morphology – A useful parameter in Renal Disease

Read more
products_default

The Role of Ret-He in Haemodialysis Patients

Read more

The Role of Ret-He in Haemodialysis Patients

Read more

Applications

products_default

Albuminuria: Its Importance in Disease Detection

Read more

Albuminuria: Its Importance in Disease Detection

Read more
SP Clavant, TM Osicka, WD Comper. Lab Medicine 2007; 38:35-38.
products_default

Diagnostic performance of reticulocyte hemoglobin equivalent in assessing the iron status.

Read more

Diagnostic performance of reticulocyte hemoglobin equivalent in assessing the iron status.

Read more
Chinudomwong, Pawadee, et al. Journal of Clinical Laboratory Analysis (2020): e23225.
products_default

Which methods for determining glomerular filtration rate most strongly associate with risk of progression of kidney disease?

Read more

Which methods for determining glomerular filtration rate most strongly associate with risk of progression of kidney disease?

Read more
Anders H Berg, Jennifer Van Eyk, Clinical Chemistry, Volume 65, Issue 3, 1 March 2019, Pages 361–362